Exploration of DNA Methylation as a Marker for Early Detection of High Grade Serous Epithelial Ovarian Cancer

Completed

Conditions studied: Epithelial Ovarian Cancer

In brief

The purpose of this study is to determine if there are markers in plasma that can be used to develop a diagnostic panel for early detection and diagnosis of high grade serous epithelial ovarian cancer.

Key facts

Study ID

NCT03622385

Run by

Baylor Research Institute

People needed

10

Starts

2019-02-19

Expected to finish

2021-09-28

Last updated by the study team

2026-01-23

Who can join

Age: 18 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Female
• 18 years of age and older
• Women with an undiagnosed pelvic mass who need to undergo diagnostic laparoscopic surgery

You may not qualify if…

• Male
• Under 18 years of age
• Women who can not give informed consent

Where it is running

• Baylor University Medical Center — Dallas, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.